Gregor Diagnostics

Gregor Diagnostics Inc. is a molecular diagnostics company based in Madison, Wisconsin, founded in 2016. The company focuses on developing innovative screening tests for prostate cancer, utilizing seminal fluid as a sample source. Its technology aims to detect prostate cancer at early stages and differentiate between indolent and aggressive forms of the disease. This capability enables physicians to minimize overdiagnosis and overtreatment of less aggressive cancer while enhancing the detection and management of more aggressive cases. Gregor Diagnostics' approach represents a significant advancement in the field of prostate cancer diagnostics.